which competes with GlaxoSmithKline's Nucala (mepolizumab) and Teva's Cinqaero (reslizumab), which have restrictions on their use. The EU approval for the pen injector has come ahead of the US ...
other biologic drugs like GlaxoSmithKline's Nucala (mepolizumab). It is the second indication for the IL-4 and IL-13 inhibitor cleared for use by the NHS in England and Wales after atopic ...
(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...
Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...
Nov. 7, 2024 — Plastic pollution exacerbates the impacts of all planetary boundaries, including climate change, ocean acidification and biodiversity loss, a new paper shows. Ahead of the final ...
CENTRAL GOVERNMENT FUNDS: Social welfare would account for the largest portion of the NT$3.33 trillion budget, followed by spending on education, tech and culture ...
If you’re searching for today’s best money market account rates, we’ve narrowed down some of the top offers. Learn more about money market account rates today. The United States has ...
Foreign leaders have rushed to ingratiate themselves with Donald J. Trump in recent days, nervously recalling the clashes, insults and feuds of his first presidency. By Mark LandlerMatina Stevis ...
A parliamentary panel is set to discuss the possibility of extending caste-based reservations to the private sector in India. The proposal, a contentious issue with significant political and ...
Expert Rev Resp Med. 2012;6(6):629-638. 1 Allergy Unit 'D. Kalogeromitros', Attikon University Hospital, University of Athens Medical School, Athens, Greece 2 Allergy Department, 2nd Pediatric ...
Study objectives: To document the existence and investigate the etiology of "thunderstorm asthma," which has been reported sporadically over the past 20 years. Design: We assessed the relationship ...